Transgender Health (Grin) Flashcards
Definition of Gender Identity
one’s internal sense of being male, female, neither, both or another gender(s)
Definition of Gender Expression
physical manifestation of one’s gender identity through clothing, hairstyle, voice, body shape; does NOT tell you about sexual orientation or gender identity
Transgender female/ trans-feminine individual
assigned male at birth, gender identity is female/feminine spectrum
Transgender male/trans-masculine individual
assigned female at birth, gender identity is male/masculine spectrum
What are 3 important roles as a physician treating transgender population?
- Understand basic aspects of transgender health
- Provide affirming, respectful care to all patients
- Help make health care a safe space for all patients
Definition of gender incongruence
sex assigned at birth does not align with gender identity
Definition of gender dysphoria
clinically significant distress or impairment related to incongruence between sex assigned at birth and gender identity
What is the goal of gender-affirming hormone therapy?
to allow acquisition of secondary characteristics more aligned with the individuals gender identity
What are the 4 criteria for initiating hormone therapy?
- marked and sustained gender incongruence
- capacity to consent for treatment
- mental health and physical conditions that could have negatively impact outcome of treatment have been assessed
- Understands effects of hormone therapy on reproduction, and have explored fertility preservation options
Is a formal mental health evaluation (ie psychiatry evaluation) required prior to initiating hormone therapy?
NO. it is not required prior to initiating treatment
Why is masculinizing hormone therapy not given orally?
Testosterone; only delivered via injection to topically; not given orally due to hepatotoxicity
Masculinizing hormone therapy effects
facial/body hair growth (onset 3-6 mo)
Scalp hair loss (onset >12 mo)
Clitoral enlargement (onset 3-6 mo)
Deepened voice (onset 3-12 mo)
Risks of masculinizing hormone therapy
Testosterone; polycythemia/erythrocytosis; monitor CBC in these patients
Feminizing hormone therapy
Estradiol and androgen blocker (spironolactone)
Feminizing hormone therapy effects
breast growth (onset 3-6 mo)
decreased testicular volume (onset 3-6 mo)